Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Windtree Therapeutics, Inc. WINT
$1.52
-$0.1 (-6.86%)
На 18:02, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
8879647.00000000
-
week52high
44.00
-
week52low
1.36
-
Revenue
0
-
P/E TTM
0
-
Beta
0.18027600
-
EPS
-55.78000000
-
Last Dividend
0.00000000
-
Next Earnings Date
03 мая 2023 г. в 10:59
Описание компании
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF, an aerosolized KL4 surfactant, which is in Phase IIb clinical trial to treat respiratory distress syndrome in premature infants; Lyophilized KL4 surfactant, which is in Phase IIa clinical trial for the treatment of lung injury resulting from COVID-19; and Rostafuroxin that is in Phase IIb clinical trial for the treatment of genetically associated hypertension. It has a collaboration with Universita degli Studi di Milano-Bicocca for the discovery and development of new SERCA2a compounds for the treatment of chronic and acute human heart failure; a strategic alliance with Laboratorios del Dr. Esteve, S.A. for the development, marketing, and sales of a portfolio of potential KL4 surfactant products; and collaboration with Battelle Memorial Institute for development of its ADS for use in its phase III program. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was incorporated in 1992 and is headquartered in Warrington, Pennsylvania. Windtree Therapeutics, Inc. is a subsidiary of Lee's Pharmaceutical Holdings Limited.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Oppenheimer | Outperform | 04 июн 2021 г. | |
| Ladenburg Thalmann | Buy | 25 ноя 2020 г. | |
| H.C. Wainwright | Buy | 25 ноя 2020 г. | |
| Ladenburg Thalmann | Buy | 26 июн 2020 г. | |
| Stifel Nicolaus | Hold | Buy | 30 июн 2017 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Fraser Craig | A | 226558 | 2500 | 27 июл 2022 г. |
| Fraser Craig | A | 224058 | 2500 | 26 июл 2022 г. |
| Hamill John P. | A | 72800 | 3000 | 26 июл 2022 г. |
| Fraser Craig | A | 221558 | 4500 | 30 июн 2022 г. |
| Fraser Craig | A | 217058 | 7000 | 29 июн 2022 г. |
| Williams Leslie J. | A | 7500 | 7500 | 07 июн 2022 г. |
| Williams Leslie J. | A | 5000 | 5000 | 07 июн 2022 г. |
| SCOTT ROBERT A | A | 7500 | 7500 | 07 июн 2022 г. |
| SCOTT ROBERT A | A | 5000 | 5000 | 07 июн 2022 г. |
| Huang James | A | 7500 | 7500 | 07 июн 2022 г. |
Новостная лента
Windtree Therapeutics, Inc. (WINT) Upgraded to Buy: Here's Why
Zacks Investment Research
18 ноя 2022 г. в 13:41
Windtree Therapeutics, Inc. (WINT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
What The Stock Market Did Today & Top Penny Stocks To Watch Now
PennyStocks
28 сент 2022 г. в 21:50
Hot penny stocks to watch & what happened in the stock market today. The post What The Stock Market Did Today & Top Penny Stocks To Watch Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Windtree to Present at the Ladenburg Thalmann Healthcare Conference
GlobeNewsWire
21 сент 2022 г. в 16:05
WARRINGTON, Pa., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular disorders, today announced that Craig Fraser, President and Chief Executive Officer, will present a corporate overview and will be available for in-person 1x1 meetings at the upcoming Ladenburg Thalmann Healthcare Conference taking place at the Sofitel Hotel in New York, NY on September 29, 2022.
Windtree to Present at the H.C. Wainwright 24th Annual Global Investment Conference
GlobeNewsWire
06 сент 2022 г. в 16:05
WARRINGTON, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular disorders, today announced that Craig Fraser, President and Chief Executive Officer, will present a corporate overview and will be available for virtual 1x1 meetings at the upcoming H.C. Wainwright 24th Annual Global Investment Conference taking place on September 12-14, 2022.
Popular Penny Stocks For Your Buy List Today? 3 to Watch
PennyStocks
24 авг 2022 г. в 06:00
Here's what you need to know about trading penny stocks on August 24th The post Popular Penny Stocks For Your Buy List Today? 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.